Covagen AG
7Patents
7Active
7Granted
44Portfolio score
Filing activity: Aug 24, 2010 → Apr 2, 2018 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9790475B2 | Human serum albumin binding compounds and fusion proteins thereof | Chemistry; Metallurgy | 4 | Active |
| US9085760B2 | Chymase binding compounds and medical uses thereof | Physics | 2 | Active |
| US9593314B2 | Binding molecules with antitumoral activity | Chemistry; Metallurgy | 1 | Active |
| US10364419B2 | Human serum albumin binding compounds and fusion proteins thereof | Chemistry; Metallurgy | 1 | Active |
| US9315557B2 | IL-17A binding molecules and medical uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10722589B2 | FGFR3 binding molecules | Chemistry; Metallurgy | 0 | Active |
| US9376477B2 | IL-17 binding compounds and medical uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.